News

Children and newborns are especially vulnerable to drug-resistant bacteria. 1 in 5 deaths caused by antibiotic resistance occur in children under the age of five, and up to 3 million newborns get serious infections that lead to sepsis every year. GARDP is working to identify and develop new treatments for children, with special attention to newborns with sepsis, as well as to provide data to inform treatment guidelines for this vulnerable group. This page focuses on sepsis in newborns, for information on our paediatric development work, please see this page.